Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins

Renal Failure

Volumn 28, Issue 7, 2006, Pages 567-571

  Kanbay, Mehmet ^a,b   Delibasi, Tuncay ^b   Kaya, Arif ^a   Aydogan, Timucin ^a   Koca, Cemile ^a   Akcay, Ali ^a   Duranay, Murat ^c   Yigitoglu, Ramazan ^a  

^a FATIH UNIVERSITY   (Turkey)

^b Numune Research and Training Hospital ^*  (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Hemodialysis; Lipid; Peritoneal dialysis

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; HEMODIALYSIS; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33750085863     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220600839761     Document Type: Article

References (21)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW;, with the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003 October 28;108(17):2154-2169.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 September 23;351(13):1296-1305.
3. De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, Strippoli M, Casino F, Giannattasio M, Petrarulo F, Virgilio M, Laraia E, Di Iorio BR, Savica V, Conte G, and the Target Blood Pressure Levels in Chronic Kidney Disease (TABLE in CKD) Study Group. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006 February;69(3):538-545.
4. Johansson AC, Samuelsson O, Attman PO, Haraldsson B, Moberly J, Knight-Gibson C, Alaupovic P. Dyslipidemia in peritoneal dialysis-relation to dialytic variables. Perit Dial Int. 2000 May-June;20(3):306-314.
5. Attman PO, Samuelsson O, Alaupovic P. Lipid metabolism and renal failure. Am J Kidney Dis 1993;21:573-592.
6. Wheeler DC. Abnormalities of lipoprotein metabolism in CAPD patients. Kidney Int. 1996 November;56(Suppl.):S41-S46.
7. Kagan A, Bar-Khayim Y, Schafer Z, Fainaru M. Kinetics of peritoneal protein loss during CAPD, II: Lipoprotein leakage and its impact on plasma lipid levels. Kidney Int. 1990 March;37(3):980-990.
8. Horkko S, Huttunen K, Laara E, Kervinen K, Kesaniemi YA. Effects of three treatment modes on plasma lipids and lipoproteins in uremic patients. Ann Med. 1994 August; 26(4):271-282.
9. Siamopoulos KC, Elisaf MS, Bairaktari HT, Pappas MB, Sferopoulos GD, Nikolakakis NG. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis. Perit Dial Int. 1995 October-December;15(8): 342-347.
10. Corboy J, Sutherland WH, Walker RJ, Robertson MC, Cox CM. Cholesteryl ester transfer in patients with renal failure or renal transplants. Kidney Int. 1994 October;46(4):1147-1153.
11. Tomura S, Nakamura Y, Doi M, Ando R, Ida T, Chida Y, Ootsuka S, Shinoda T, Yanagi H, Tsuchiya S, Marumo F. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 1996 June;27(6):848-854.
12. Kandoussi A, Cachera C, Reade R, Pagniez D, Fruchart JC, Tacquet A. Apo AIV in plasma and dialysate fluid of CAPD patients: comparison with other apolipoproteins. Nephrol Dial Transplant. 1992;7(10):1026-1029.
13. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int. 1992 June;41(6):1653-1661.
14. Corboy J, Sutherland WH, Walker RJ, Robertson MC, Cox CM. Cholesteryl ester transfer in patients with renal failure or renal transplants. Kidney Int. 1994 October;46(4):1147-1153.
15. Tomura S, Nakamura Y, Doi M, Ando R, Ida T, Chida Y, Ootsuka S, Shinoda T, Yanagi H, Tsuchiya S, Marumo F. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 1996 June;27(6):848-854.
16. Little J, Phillips L, Russell L, Griffiths A, Russell GI, Davies SJ. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors. J Am Soc Nephrol. 1998 October;9(10):1931- 1939.
17. Sniderman A, Cianflone K, Kwiterovich PO Jr, Hutchinson T, Barre P, Prichard S. Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis. Atherosclerosis. 1987 June;65(3):257-264.
18. Kronenberg F, Konig P, Neyer U, Auinger M, Pribasnig A, Meisl T, Pinter G, Dieplinger H. Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study. Thromb Haemost. 1995 October;74(4):1025-1028.
19. Wheeler DC, Bernard DB. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment. Am J Kidney Dis. 1994 March;23(3):331-346.
20. Churchill DN. Comparative morbidity among hemodialysis and continuous ambulatory peritoneal dialysis patients. Kidney Int. 1993 February;40(Suppl.): S16-S22.
21. Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Kidney Int. 1999 April;55(4):1536- 1542.